1. Efficacy and safety of mij821 in patients with treatment-resistant depression: Results from a randomized, placebo-controlled, proof-of-concept study. (13th April 2021) Authors: Ghaemi, N.; Sverdlov, A.; Shelton, R.; Litman, R. Journal: European psychiatry Issue: Volume 64:Supplement 1(2021) Page Start: S334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗